A former hedge fund manager is justifying his startup company's decision to increase the price of a life-saving drug from $13.50 per pill to $750 by saying it's necessary in order to create better medicine in the future. Martin Shkreli's Turing Pharmaceuticals acquired the drug Daraprim in August, The Guardian reports, which is used to treat toxoplasmosis, an infection that can be fatal when it affects babies born to infected mothers and people with compromised immune systems due to AIDS and certain cancers.
Ceo Defends Raising Price Of Drug From $13.50 A Pill To $750: 'we Have To Turn A Profit'
OnlineEditor@theweek.com (Catherine Garcia), The Week
Mon, 09/21/2015 - 7:41pm
Topics: martin shkreli's turing pharmaceuticals august the guardian bloomberg news world health organization's list essential medicines the hiv medicine association infectious diseases society america september shkreli monday daraprim turing pharmaceuticals shkreli daraprim price drug pill turn a profit increase company
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more